VENTYX BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.74 USD | -1.86% |
|
+13.67% | +91.90% |
| 05-16 | Ventyx Biosciences Appoints Matthew Moore as Chief Operating Officer; Shares Rise | MT |
| 05-16 | Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer | CI |
Chart calendar Ventyx Biosciences, Inc.
9850acd5.By0pOCfLMDatPpzOkW6LhAIxNmsZKgknLpxqP2eDLwY.MEdab3_6BlvkUduv5SPA6DpoTl1hSzhBWKkYCgDRSlU_T0NsYPNfR-YK6w~483f452b1f36e430870b3e7bcc3fe68c
Upcoming events on Ventyx Biosciences, Inc.
Past events on Ventyx Biosciences, Inc.
| 2024-05-09 16:30 | Q1 2024 Earnings Call |
| 2024-05-09 16:01 | Q1 2024 Earnings Release |
| 2024-03-14 10:45 | Barclays Global Healthcare Conference |
| 2024-03-12 | Jefferies Biotech on the Bay Summit |
| 2024-03-11 11:00 | Business Update Call |
| 2024-02-27 16:01 | Q4 2023 Earnings Release |
| 2024-02-22 07:30 | European Crohn and Colitis Organisation Congress |
| 2024-02-13 11:20 | Oppenheimer Healthcare Life Sciences Conference |
| 2023-11-28 13:30 | Piper Sandler Healthcare Conference |
| 2023-11-16 04:30 | Jefferies London Healthcare Conference |
| 2023-11-06 16:30 | VTX958 Phase 2 Trial Results Call |
| 2023-10-09 16:30 | VTX002 Phase 2 Results Call |
| 2023-09-13 08:50 | Morgan Stanley Global Healthcare Conference |
| 2023-09-07 14:15 | Wells Fargo Healthcare Conference |
| 2023-08-10 16:30 | Q2 2023 Earnings Call |
| 2023-08-10 16:01 | Q2 2023 Earnings Release |
| 2023-08-09 16:30 | Canaccord Genuity Growth Conference |
| 2023-06-15 11:40 | Goldman Sachs Global Healthcare Conference |
| 2023-06-07 13:00 | Annual General Meeting |
| 2023-06-07 09:00 | Jefferies Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -113 -102 -10.53% | -208 -190 -9.65% | -163 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -67,1 -64,2 -4.56% | -113 -108 -4.73% | -208 -209 0.35% | -164 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -83,7 -80,3 -4.23% | -108 -111 1.88% | -193 -206 6.53% | -162 |
|
Net income Million USD | Released Forecast Spread | -28,2 | -85,3 -81,4 -4.79% | -108 -110 1.32% | -193 -206 6.11% | -160 |
|
EPS USD | Released Forecast Spread | -14,2 | -6,65 -7,52 11.55% | -2,07 -2,09 0.77% | -3,30 -3,42 3.6% | -2,43 |
| Announcement Date | 20/08/21 | 23/03/22 | 23/03/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -22,7 -19,9 -14.03% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -22,7 -18,2 -24.93% | -20,4 -22,8 10.5% | -31,4 -22,3 -40.7% | -38,6 -35,8 -7.73% | -42,6 -38,1 -11.59% | -57,1 -43,7 -30.72% | -58,0 -56,1 -3.24% | -50,3 -57,0 11.61% | -41,8 -43,2 3.42% | -40,7 | -41,0 | -43,1 | -41,3 | -41,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,7 -17,2 -31.8% | -20,0 -22,7 11.94% | -30,5 -22,2 -37.13% | -35,2 -37,6 6.45% | -38,9 -36,8 -5.75% | -53,3 -42,6 -25.15% | -54,0 -53,8 -0.43% | -46,8 -56,9 17.85% | -38,6 -43,7 11.73% | -39,4 | -40,1 | -43,6 | -48,2 | -48,8 |
|
Net income Million USD | Released Forecast Spread | -22,7 -17,8 -27.72% | -20,0 -23,0 12.78% | -30,5 -22,3 -36.37% | -35,2 -36,7 4.03% | -38,9 -37,3 -4.47% | -53,3 -42,2 -26.13% | -54,0 -53,8 -0.35% | -46,8 -56,5 17.31% | -38,6 -41,2 6.47% | -39,2 | -39,5 | -42,2 | -39,6 | -40,1 |
|
EPS USD | Released Forecast Spread | -0,45 -0,52 13.46% | -0,39 -0,45 13.65% | -0,59 -0,44 -33.71% | -0,62 -0,64 3.63% | -0,68 -0,65 -4.39% | -0,91 -0,71 -27.5% | -0,92 -0,89 -3.23% | -0,79 -0,89 11.61% | -0,62 -0,67 7.07% | -0,59 | -0,58 | -0,61 | -0,58 | -0,58 |
| Announcement Date | 12/05/22 | 15/08/22 | 03/11/22 | 23/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 27/02/24 | 09/05/24 | - | - | - | - | - |
More events
Past sector events for Ventyx Biosciences, Inc.
| 2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-15 16:01 | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VTYX Stock
- Calendar Ventyx Biosciences, Inc.
